跳至主要内容
临床试验/ISRCTN72835417
ISRCTN72835417已完成不适用

A randomized double blind controlled study to determine whether the use of colchicine is effective in reducing the incidence of atrial fibrillation after coronary artery by-pass grafting

Catholic University of the Sacred Heart-Rome (Italy)0 个研究点目标入组 320 人开始时间: 2013年7月10日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
320

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

性别
All

入选标准

  • All the patients electively submitted to coronary artery by-pass grafting with arterial conduits and without contraindications to colchicine

排除标准

  • 1. Patients with preoperative atrial fibrillation
  • 2. Known contraindication to Colchicine
  • 3. Transaminases on admission more that 1.5 times the normal values
  • 4. Creatinine clearance less than 30 ml/min
  • 5. History of myopathy or elevated creatinine kinase
  • 6. Hematologic disease
  • 7. Gastrointestinal disease
  • 8. Presence of systemic inflammatory or autoimmune disease

研究者

发起方
Catholic University of the Sacred Heart-Rome (Italy)

相似试验

COlchicine for the preVention of postopErative... | 临床试验